Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer.
The four-kallikrein panel and the Prostate Health Index (PHI) have been shown to improve prediction of prostate cancer (PCa) compared with prostate-specific antigen (PSA). No comparison of the four-kallikrein panel and PHI has been presented.
